Frequently Asked Questions

An honest look at the evidence for exosome therapy, what the mechanism is, what remains unproven, and how to evaluate a clinic offering it.

Testicular atrophy on testosterone replacement therapy — why it happens, how common it is, and what can be done about it.

The process for Wharton's Jelly treatment in Lighthouse Point, FL — assessment, physician review under SB 1768, and what happens at the visit.

How long exosome therapy lasts — the difference between how long the vesicles survive and how long the biological response continues.

Whether testosterone replacement therapy is covered by insurance, what coverage usually depends on, and how Rebuild Regen handles it.

Wharton's Jelly and stem cells are related but not the same thing. What the distinction is, and what a Wharton's Jelly preparation actually contains.

PRP versus exosome therapy compared: source material, signalling profile, autologous versus allogeneic, and which suits which presentation.

An honest account of the limitations of regenerative medicine: cost, variable response, limited insurance coverage, and the difference between approved and.

Newer approaches to peripheral neuropathy that address nerve health and circulation rather than only blocking the pain signal.

Which specialties treat peripheral neuropathy, what each contributes, and why the underlying cause determines who should be managing it.

Not everyone is a candidate for stem cell therapy. The presentations and health conditions that make someone unsuitable, and what is offered instead.

Why many physicians are cautious about testosterone therapy — fertility suppression, hematocrit, prostate monitoring, and the reversible causes that get missed.